| scholarly article | Q13442814 |
| P8978 | DBLP publication ID | journals/jcisd/KorbSE09 |
| P356 | DOI | 10.1021/CI800298Z |
| P698 | PubMed publication ID | 19125657 |
| P50 | author | Thomas Stützle | Q56524110 |
| P2093 | author name string | Oliver Korb | |
| Thomas E Exner | |||
| P433 | issue | 1 | |
| P304 | page(s) | 84-96 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Journal of Chemical Information and Modeling | Q3007982 |
| P1476 | title | Empirical scoring functions for advanced protein-ligand docking with PLANTS | |
| P478 | volume | 49 |
| Q50029498 | 3D-e-Chem: Structural Cheminformatics Workflows for Computer-Aided Drug Discovery. |
| Q92955278 | A Comparative Linear Interaction Energy and MM/PBSA Study on SIRT1-Ligand Binding Free Energy Calculation |
| Q39425242 | A D3R prospective evaluation of machine learning for protein-ligand scoring. |
| Q64168599 | A Diverse Benchmark Based on 3D Matched Molecular Pairs for Validating Scoring Functions |
| Q89787743 | A High-Throughput Screening Identifies MICU1 Targeting Compounds |
| Q49714374 | A Non-imaging High Throughput Approach to Chemical Library Screening at the Unmodified Adenosine-A3 Receptor in Living Cells. |
| Q56979547 | A Novel Generalized 3D-QSAR Model of Camptothecin Analogs |
| Q92589180 | A Practical Perspective: The Effect of Ligand Conformers on the Negative Image-Based Screening |
| Q40273021 | A capture method based on the VC1 domain reveals new binding properties of the human receptor for advanced glycation end products (RAGE). |
| Q27700206 | A combination of spin diffusion methods for the determination of protein-ligand complex structural ensembles |
| Q89701247 | A conserved strategy of chalcone isomerase-like protein to rectify promiscuous chalcone synthase specificity |
| Q28282247 | A consistent description of HYdrogen bond and DEhydration energies in protein-ligand complexes: methods behind the HYDE scoring function |
| Q28304560 | A machine learning-based method to improve docking scoring functions and its application to drug repurposing |
| Q37318187 | A method for predicting individual residue contributions to enzyme specificity and binding-site energies, and its application to MTH1. |
| Q52352133 | A novel interaction fingerprint derived from per atom score contributions: exhaustive evaluation of interaction fingerprint performance in docking based virtual screening. |
| Q60915049 | A novel scaffold for EGFR inhibition: Introducing N-(3-(3-phenylureido)quinoxalin-6-yl) acrylamide derivatives |
| Q34041244 | A python-based docking program utilizing a receptor bound ligand shape: PythDock. |
| Q94211057 | ACID: a free tool for drug repurposing using consensus inverse docking strategy |
| Q41511323 | AMMOS2: a web server for protein-ligand-water complexes refinement via molecular mechanics |
| Q90114259 | Activation Effects of Carnosine- and Histidine-Containing Dipeptides on Human Carbonic Anhydrases: A Comprehensive Study |
| Q47991923 | Allosteric inhibition of carnosinase (CN1) by inducing a conformational shift |
| Q35312348 | Allosteric model of maraviroc binding to CC chemokine receptor 5 (CCR5). |
| Q55385594 | An Efficient Implementation of the Nwat-MMGBSA Method to Rescore Docking Results in Medium-Throughput Virtual Screenings. |
| Q40669788 | An NMR-based scoring function improves the accuracy of binding pose predictions by docking by two orders of magnitude |
| Q38289881 | Antagonists of the miRNA-Argonaute 2 Protein Complex: Anti-miR-AGOs |
| Q56452360 | Antimalarial drug discovery targeting apical membrane antigen 1 |
| Q27902289 | Applying DEKOIS 2.0 in structure-based virtual screening to probe the impact of preparation procedures and score normalization |
| Q47348677 | Approaches for Differentiation and Interconverting GPCR Agonists and Antagonists |
| Q83199715 | Are predefined decoy sets of ligand poses able to quantify scoring function accuracy? |
| Q57010544 | Aryl Bis-Sulfonamide Inhibitors of IspF fromArabidopsis thalianaandPlasmodium falciparum |
| Q38632776 | Assessing hERG pore models as templates for drug docking using published experimental constraints: the inactivated state in the context of drug block |
| Q51127935 | Assessing protein-ligand docking for the binding of organometallic compounds to proteins. |
| Q90638982 | Be Aware of Aggregators in the Search for Potential Human ecto-5'-Nucleotidase Inhibitors |
| Q58853545 | Bicyclic γ-amino acids as inhibitors of γ-aminobutyrate aminotransferase |
| Q36432395 | Binding Mode Selection Determines the Action of Ecstasy Homologs at Monoamine Transporters |
| Q64062455 | Binding mode information improves fragment docking |
| Q47552878 | Biological activity, quantitative structure-activity relationship analysis, and molecular docking of xanthone derivatives as anticancer drugs. |
| Q50670958 | Boosting Pose Ranking Performance via Rescoring with MM-GBSA. |
| Q58719254 | Bridging Molecular Docking to Molecular Dynamics in Exploring Ligand-Protein Recognition Process: An Overview |
| Q30392359 | Broad Spectrum Anti-Influenza Agents by Inhibiting Self-Association of Matrix Protein 1. |
| Q30387722 | CSAR 2014: A Benchmark Exercise Using Unpublished Data from Pharma |
| Q36451249 | Carboxylesterase converts Amplex red to resorufin: Implications for mitochondrial H2O2 release assays |
| Q92756833 | Chain-Branched Polyhydroxylated Octahydro-1H-Indoles as Potential Leads against Lysosomal Storage Diseases |
| Q37848281 | Challenges and advances in computational docking: 2009 in review |
| Q90529267 | Chaos-embedded particle swarm optimization approach for protein-ligand docking and virtual screening |
| Q38944415 | Characterisation of taxlllaids A-G; natural products from Xenorhabdus indica. |
| Q51313805 | Characteristics of the Protoporphyrin IX Binding Sites on Human Serum Albumin Using Molecular Docking. |
| Q89835194 | Characterization of Glyceollins as Novel Aryl Hydrocarbon Receptor Ligands and Their Role in Cell Migration |
| Q42364420 | Characterization of the Annonaceous acetogenin, annonacinone, a natural product inhibitor of plasminogen activator inhibitor-1. |
| Q56983552 | Combination of spectroscopic and computational methods to get an understanding of supramolecular chemistry of drugs: from simple host systems to biomolecules |
| Q37217664 | Combined Approach of Patch-Surfer and PL-PatchSurfer for Protein-Ligand Binding Prediction in CSAR 2013 and 2014. |
| Q90692816 | Combining Molecular Dynamics and Docking Simulations to Develop Targeted Protocols for Performing Optimized Virtual Screening Campaigns on The hTRPM8 Channel |
| Q38608749 | Combining self- and cross-docking as benchmark tools: the performance of DockBench in the D3R Grand Challenge 2. |
| Q38298563 | Comparative evaluation of several docking tools for docking small molecule ligands to DC-SIGN. |
| Q36479708 | Comparison of the binding and functional properties of two structurally different D2 dopamine receptor subtype selective compounds |
| Q38641282 | Comprehensive and Automated Linear Interaction Energy Based Binding-Affinity Prediction for Multifarious Cytochrome P450 Aromatase Inhibitors |
| Q27307600 | Computational Docking Study of p7 Ion Channel from HCV Genotype 3 and Genotype 4 and Its Interaction with Natural Compounds |
| Q35589799 | Computational and biophysical approaches to protein-protein interaction inhibition of Plasmodium falciparum AMA1/RON2 complex. |
| Q52856612 | Constructing and Validating 3D-pharmacophore Models to a Set of MMP-9 Inhibitors for Designing Novel Anti-melanoma Agents. |
| Q45945644 | Convex-PL: a novel knowledge-based potential for protein-ligand interactions deduced from structural databases using convex optimization. |
| Q89543575 | Convolutional neural network scoring and minimization in the D3R 2017 community challenge |
| Q58558877 | Could the presence of sodium ion influence the accuracy and precision of the ligand-posing in the human A adenosine receptor orthosteric binding site using a molecular docking approach? Insights from Dockbench |
| Q24633082 | Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor |
| Q36447801 | DARC: Mapping Surface Topography by Ray-Casting for Effective Virtual Screening at Protein Interaction Sites |
| Q36385700 | Data from docking simulations to develop an efficient strategy able to evaluate the interactions between RAGE and MDA-induced albumin adducts |
| Q57230718 | Design, Synthesis, and Evaluation of Acrylamide Derivatives as Direct NLRP3 Inflammasome Inhibitors |
| Q60162743 | Development of NMR and thermal shift assays for the evaluation of isocitrate lyase inhibitors |
| Q47711109 | Development of novel fluorescent histamine H1-receptor antagonists to study ligand-binding kinetics in living cells |
| Q34985496 | Dialkylresorcinols as bacterial signaling molecules |
| Q59661528 | Diazabicyclo analogues of maraviroc: synthesis, modeling, NMR studies and antiviral activity |
| Q24610075 | Diazepam-bound GABAA receptor models identify new benzodiazepine binding-site ligands |
| Q58705939 | Discovery of (phenylureido)piperidinyl benzamides as prospective inhibitors of bacterial autolysin E from Staphylococcus aureus |
| Q27676380 | Discovery of Novel Trypanosoma brucei Phosphodiesterase B1 Inhibitors by Virtual Screening against the Unliganded TbrPDEB1 Crystal Structure |
| Q43633532 | Discovery of Schaeffer's acid analogues as lead structures of mycobacterium tuberculosis type II dehydroquinase using a rational drug design approach. |
| Q64376773 | Discovery of small molecule inhibitors of adenovirus by disrupting E3-19K/HLA-A2 interactions |
| Q48238825 | Disruptor of telomeric silencing 1-like (DOT1L): disclosing a new class of non-nucleoside inhibitors by means of ligand-based and structure-based approaches |
| Q91612423 | Dissecting the role of novel EZH2 inhibitors in primary glioblastoma cell cultures: effects on proliferation, epithelial-mesenchymal transition, migration, and on the pro-inflammatory phenotype |
| Q48280219 | DockBench as docking selector tool: the lesson learned from D3R Grand Challenge 2015. |
| Q35649682 | DockBench: An Integrated Informatic Platform Bridging the Gap between the Robust Validation of Docking Protocols and Virtual Screening Simulations. |
| Q36098710 | Docking and scoring with ICM: the benchmarking results and strategies for improvement |
| Q30607323 | Docking challenge: protein sampling and molecular docking performance |
| Q35926542 | Drug repurposing to target Ebola virus replication and virulence using structural systems pharmacology |
| Q92460746 | Dual-active antifungal agents containing strobilurin and SDHI-based pharmacophores |
| Q33830749 | Effect of Binding Pose and Modeled Structures on SVMGen and GlideScore Enrichment of Chemical Libraries |
| Q44187754 | Effect of pH and ligand charge state on BACE-1 fragment docking performance |
| Q43008057 | Efficient conformational sampling and weak scoring in docking programs? Strategy of the wisdom of crowds. |
| Q99589369 | Efficient consideration of coordinated water molecules improves computational protein-protein and protein-ligand docking discrimination |
| Q41125977 | Engineered factor Xa variants retain procoagulant activity independent of direct factor Xa inhibitors. |
| Q33916690 | Enhance the performance of current scoring functions with the aid of 3D protein-ligand interaction fingerprints |
| Q50940415 | Enhancing the Reliability of GPCR Models by Accounting for Flexibility of Their Pro-Containing Helices: the Case of the Human mAChR1 Receptor. |
| Q33966870 | Enrichment of chemical libraries docked to protein conformational ensembles and application to aldehyde dehydrogenase 2 |
| Q39951742 | Estimation of the applicability domain of kernel-based machine learning models for virtual screening |
| Q52577337 | Experimental and in silico analysis of cordycepin and its derivatives as endometrial cancer treatment. |
| Q57017519 | Experimental, DFT and docking simulations of the binding of diapocynin to human serum albumin: induced circular dichroism |
| Q57372287 | Exploring the Behavior of Bovine Serum Albumin in Response to Changes in the Chemical Composition of Responsive Polymers: Experimental and Simulation Studies |
| Q55312267 | Exploring the Structural Diversity in Inhibitors of α-Synuclein Amyloidogenic Folding, Aggregation, and Neurotoxicity. |
| Q64095641 | Extensive Reliability Evaluation of Docking-Based Target-Fishing Strategies |
| Q63246733 | Flavonoids as Putative Epi-Modulators: Insight into Their Binding Mode with BRD4 Bromodomains Using Molecular Docking and Dynamics |
| Q86587399 | Fluorescence and Docking Studies of the Interaction between Human Serum Albumin and Pheophytin |
| Q28276613 | Function-specific virtual screening for GPCR ligands using a combined scoring method |
| Q47274809 | GPCR Modulation of Thieno[2,3-b]pyridine Anti-Proliferative Agents. |
| Q47565870 | GalaxyDock BP2 score: a hybrid scoring function for accurate protein-ligand docking |
| Q91763848 | Getting Docking into Shape Using Negative Image-Based Rescoring |
| Q34584095 | Glucose 6P binds and activates HlyIIR to repress Bacillus cereus haemolysin hlyII gene expression |
| Q45789496 | Guiding protein-ligand docking with different experimental NMR-data. |
| Q93121951 | High-Resolution Structure of ClpC1-Rufomycin and Ligand Binding Studies Provide a Framework to Design and Optimize Anti-Tuberculosis Leads |
| Q30396689 | Identification of CLK1 Inhibitors by a Fragment-linking Based Virtual Screening |
| Q39252246 | Identification of novel anaplastic lymphoma kinase (ALK) inhibitors using a common feature pharmacophore model derived from known ligands crystallized with ALK. |
| Q92951662 | Impressive Enrichment of Semiempirical Quantum Mechanics-Based Scoring Function: HSP90 Protein with 4541 Inhibitors and Decoys |
| Q31135416 | Improved pose and affinity predictions using different protocols tailored on the basis of data availability |
| Q47796595 | Improved protein-ligand binding affinity prediction by using a curvature-dependent surface-area model |
| Q54963827 | Improving Docking Performance Using Negative Image-Based Rescoring. |
| Q39177512 | Improving scoring-docking-screening powers of protein-ligand scoring functions using random forest |
| Q40117005 | Improving the iterative Linear Interaction Energy approach using automated recognition of configurational transitions |
| Q34500763 | In Silico Prediction of Human Sulfotransferase 1E1 Activity Guided by Pharmacophores from Molecular Dynamics Simulations. |
| Q36094897 | In Silico Predictions of Drug - Drug Interactions Caused by CYP1A2, 2C9 and 3A4 Inhibition - a Comparative Study of Virtual Screening Performance |
| Q89597711 | In Silico Strategies in Tuberculosis Drug Discovery |
| Q90574348 | In Silico and In Vitro Anti-Helicobacter Pylori Effects of Combinations of Phytochemicals and Antibiotics |
| Q41110574 | In vitro characterisation of a pleconaril/pirodavir-like compound with potent activity against rhinoviruses. |
| Q35996541 | Inhibition of neuraminidase by Ganoderma triterpenoids and implications for neuraminidase inhibitor design |
| Q50212129 | Inhibition of pro-/active MMP-2 by green tea catechins and prediction of their interaction by molecular docking studies. |
| Q38644511 | Inhibition studies of DNA methyltransferases by maleimide derivatives of RG108 as non-nucleoside inhibitors. |
| Q46715651 | Inhibitory effects and oxidation of 6-methylcoumarin, 7-methylcoumarin and 7-formylcoumarin via human CYP2A6 and its mouse and pig orthologous enzymes |
| Q45208382 | Insight into the structural similarity between HIV protease and secreted aspartic protease-2 and binding mode analysis of HIV-Candida albicans inhibitors |
| Q27703595 | Insights into regioselective metabolism of mefenamic acid by cytochrome P450 BM3 mutants through crystallography, docking, molecular dynamics, and free energy calculations |
| Q42324929 | Interfacial activation of M37 lipase: A multi-scale simulation study. |
| Q44895743 | Investigating the hydrogen-bond acceptor site of the nicotinic pharmacophore model: a computational and experimental study using epibatidine-related molecular probes |
| Q47720805 | Investigation into Improving the Aqueous Solubility of the Thieno[2,3-b]pyridine Anti-Proliferative Agents. |
| Q40525758 | Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding fragments |
| Q52936807 | IsoCombretaQuinazolines: Potent Cytotoxic Agents with Antitubulin Activity. |
| Q39535312 | Key Structural Features of Azanaphthoquinone Annelated Pyrrole Derivative as Anticancer Agents Based on the Rational Drug Design Approaches. |
| Q90193662 | Key Topics in Molecular Docking for Drug Design |
| Q37053828 | Lessons learned in empirical scoring with smina from the CSAR 2011 benchmarking exercise |
| Q42455386 | Leukaemic cells from chronic lymphocytic leukaemia patients undergo apoptosis following microtubule depolymerization and Lyn inhibition by nocodazole |
| Q47579891 | LigDockCSA: protein-ligand docking using conformational space annealing. |
| Q42288110 | Ligand Identification Scoring Algorithm (LISA). |
| Q41771553 | Ligand and structure-based classification models for prediction of P-glycoprotein inhibitors |
| Q59489014 | Ligand-, structure- and pharmacophore-based molecular fingerprints: a case study on adenosine A1, A2A, A2B, and A3 receptor antagonists |
| Q28550779 | Linear Interaction Energy Based Prediction of Cytochrome P450 1A2 Binding Affinities with Reliability Estimation |
| Q92025935 | Local Interaction Density (LID), a Fast and Efficient Tool to Prioritize Docking Poses |
| Q45946918 | Machine Learning Consensus Scoring Improves Performance Across Targets in Structure-Based Virtual Screening. |
| Q56687985 | Mapping histamine H4receptor–ligand binding modes |
| Q36503781 | Modeling the evolution of drug resistance in malaria |
| Q41061564 | Molecular Docking, Molecular Dynamics, and Structure-Activity Relationship Explorations of 14-Oxygenated N-Methylmorphinan-6-ones as Potent μ-Opioid Receptor Agonists |
| Q26800097 | Molecular docking and structure-based drug design strategies |
| Q50109862 | Molecular docking-based design and development of a highly selective probe substrate for UDP-glucuronosyltransferase 1A10. |
| Q36094967 | NMR-Assisted Molecular Docking Methodologies |
| Q43516252 | NMR-guided molecular docking of a protein-peptide complex based on ant colony optimization |
| Q51042844 | Nanodiscs for INPHARMA NMR Characterization of GPCRs: Ligand Binding to the Human A2A Adenosine Receptor. |
| Q51741958 | Neocarzinostatin-based hybrid biocatalysts for oxidation reactions. |
| Q36229913 | Neurotoxicity of a Biopesticide Analog on Zebrafish Larvae at Nanomolar Concentrations |
| Q48206344 | New Anti-Seizure (Arylalkyl)azole Derivatives: Synthesis, In Vivo and In Silico Studies. |
| Q91657183 | New HSV-1 Anti-Viral 1'-Homocarbocyclic Nucleoside Analogs with an Optically Active Substituted Bicyclo[2.2.1]Heptane Fragment as a Glycoside Moiety |
| Q90750210 | New Hydrazinothiazole Derivatives of Usnic Acid as Potent Tdp1 Inhibitors |
| Q90693027 | New Substituted Benzoylthiourea Derivatives: From Design to Antimicrobial Applications |
| Q61453568 | New Water-Soluble Copper(II) Complexes with Morpholine-Thiosemicarbazone Hybrids: Insights into the Anticancer and Antibacterial Mode of Action |
| Q34133912 | New pyrrole derivatives with potent tubulin polymerization inhibiting activity as anticancer agents including hedgehog-dependent cancer |
| Q56833662 | New tools for carbohydrate sulfation analysis: heparan sulfate 2--sulfotransferase (HS2ST) is a target for small-molecule protein kinase inhibitors |
| Q56994432 | New tools for evaluating protein tyrosine sulfation: tyrosylprotein sulfotransferases (TPSTs) are novel targets for RAF protein kinase inhibitors |
| Q52644553 | Novel Semisynthetic Derivatives of Bile Acids as Effective Tyrosyl-DNA Phosphodiesterase 1 Inhibitors. |
| Q57823510 | One Step Beyond: Design of Substrates Spanning Primed Positions of Zika Virus NS2B-NS3 Protease |
| Q27998698 | Optimal assignment methods for ligand-based virtual screening |
| Q36805380 | Optimization of 2-phenylcyclopropylmethylamines as selective serotonin 2C receptor agonists and their evaluation as potential antipsychotic agents |
| Q34625066 | Optimization of molecular docking scores with support vector rank regression |
| Q30984731 | Overview of Probing Protein-Ligand Interactions Using NMR. |
| Q36121162 | PEPSI-Dock: a detailed data-driven protein-protein interaction potential accelerated by polar Fourier correlation |
| Q61818571 | PeptoGrid-Rescoring Function for AutoDock Vina to Identify New Bioactive Molecules from Short Peptide Libraries |
| Q27675921 | Phosphodeoxyribosyltransferases, Designed Enzymes for Deoxyribonucleotides Synthesis |
| Q27345457 | Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region |
| Q48159532 | Poly-N-Acetyllactosamine Neo-Glycoproteins as Nanomolar Ligands of Human Galectin-3: Binding Kinetics and Modeling |
| Q39647348 | Pose prediction and virtual screening performance of GOLD scoring functions in a standardized test. |
| Q89993923 | Practical Model Selection for Prospective Virtual Screening |
| Q34060024 | Predicting protein ligand binding motions with the conformation explorer |
| Q40551036 | Prediction of the substrate for nonribosomal peptide synthetase (NRPS) adenylation domains by virtual screening |
| Q92257925 | Promising New Inhibitors of Tyrosyl-DNA Phosphodiesterase I (Tdp 1) Combining 4-Arylcoumarin and Monoterpenoid Moieties as Components of Complex Antitumor Therapy |
| Q93202753 | Prospects of multitarget drug designing strategies by linking molecular docking and molecular dynamics to explore the protein-ligand recognition process |
| Q118162841 | Protein homology modeling, docking, and phylogenetic analyses of an endo-1,4-β-xylanase GH11 of Colletotrichum lindemuthianum |
| Q38860867 | Protein-Ligand Scoring with Convolutional Neural Networks. |
| Q35277996 | Protein-ligand structure guided by backbone and side-chain proton chemical shift perturbations |
| Q36898003 | Putative histidine kinase inhibitors with antibacterial effect against multi-drug resistant clinical isolates identified by in vitro and in silico screens |
| Q34656041 | PyPLIF: Python-based Protein-Ligand Interaction Fingerprinting. |
| Q41060460 | Pyrazolopyrimidines: Potent Inhibitors Targeting the Capsid of Rhino- and Enteroviruses |
| Q48011252 | Pyrones as bacterial signaling molecules. |
| Q47217749 | Ranking Power of the SQM/COSMO Scoring Function on Carbonic Anhydrase II-Inhibitor Complexes |
| Q40142168 | Receptor-Guided De Novo Design of Dengue Envelope Protein Inhibitors. |
| Q38783140 | Receptor-ligand molecular docking |
| Q51699441 | Reliability analysis and optimization of the consensus docking approach for the development of virtual screening studies. |
| Q42117713 | Removal of substrate inhibition and increase in maximal velocity in the short chain dehydrogenase/reductase salutaridine reductase involved in morphine biosynthesis |
| Q64949997 | Rescoring and Linearly Combining: A Highly Effective Consensus Strategy for Virtual Screening Campaigns. |
| Q44062393 | Reversible covalent inhibition of eEF-2K by carbonitriles. |
| Q60919784 | Revisiting the halogen bonding between phosphodiesterase type 5 and its inhibitors |
| Q90727099 | Role of nitric oxide-scavenging activity of Karanjin and Pongapin in the treatment of Psoriasis |
| Q91631033 | Route to Prolonged Residence Time at the Histamine H1 Receptor: Growing from Desloratadine to Rupatadine |
| Q40916580 | S4MPLE--Sampler for Multiple Protein-Ligand Entities: Methodology and Rigid-Site Docking Benchmarking |
| Q96834988 | SQM/COSMO Scoring Function: Reliable Quantum-Mechanical Tool for Sampling and Ranking in Structure-Based Drug Design |
| Q91795691 | Small Molecule Inhibitors of KDM5 Histone Demethylases Increase the Radiosensitivity of Breast Cancer Cells Overexpressing JARID1B |
| Q38377950 | Software Infrastructure for Computer-aided Drug Discovery and Development, a Practical Example with Guidelines |
| Q39310583 | Software for molecular docking: a review. |
| Q50488437 | Solvent-free synthesis, DNA-topoisomerase II activity and molecular docking study of new asymmetrically N,N'-substituted ureas. |
| Q51226537 | Spectroscopic Studies on the Molecular Ageing of Serum Albumin. |
| Q47956171 | Structural Effects of Some Relevant Missense Mutations on the MECP2-DNA Binding: A MD Study Analyzed by Rescore+, a Versatile Rescoring Tool of the VEGA ZZ Program |
| Q42241779 | Structural and docking studies of potent ethionamide boosters |
| Q27671720 | Structural and mechanistic insights into bisphenols action provide guidelines for risk assessment and discovery of bisphenol A substitutes |
| Q41232999 | Structural insights into adiponectin receptors suggest ceramidase activity. |
| Q56854167 | Structure based virtual screening to discover putative drug candidates: Necessary considerations and successful case studies |
| Q60300327 | Structure of a human intramembrane ceramidase explains enzymatic dysfunction found in leukodystrophy |
| Q46148191 | Structure prediction of gBP21 protein of L. donovani and its molecular interaction |
| Q54965030 | Structure-Activity Relationship Analysis of 3-Phenylcoumarin-Based Monoamine Oxidase B Inhibitors. |
| Q36332768 | Structure-Based Target-Specific Screening Leads to Small-Molecule CaMKII Inhibitors. |
| Q36134510 | Structure-based approach for identification of novel phenylboronic acids as serine-β-lactamase inhibitors. |
| Q36370646 | Structure-based design of eugenol analogs as potential estrogen receptor antagonists |
| Q48023914 | Structure-based drug design, synthesis and biological assays of P. falciparum Atg3-Atg8 protein-protein interaction inhibitors. |
| Q56991394 | Structure-based virtual screening for fragment-like ligands of the G protein-coupled histamine H4 receptor |
| Q42998302 | Substrate profiling of Zika virus NS2B-NS3 protease. |
| Q26823990 | Surfing the Protein-Protein Interaction Surface Using Docking Methods: Application to the Design of PPI Inhibitors |
| Q89984716 | Synergistic Effect of 1,3,6-Trihydroxy-4,5,7-Trichloroxanthone in Combination with Doxorubicin on B-Cell Lymphoma Cells and Its Mechanism of Action Through Molecular Docking |
| Q55232052 | Synthesis and Characterization of a Bidirectional Photoswitchable Antagonist Toolbox for Real-Time GPCR Photopharmacology. |
| Q36626953 | Synthesis and biological evaluation of a new series of 1,2,4-triazolo[1,5-a]-1,3,5-triazines as human A(2A) adenosine receptor antagonists with improved water solubility |
| Q35210379 | Synthesis and biological evaluation of pyrido[2,3-d]pyrimidine-2,4-dione derivatives as eEF-2K inhibitors. |
| Q42717133 | Synthesis and molecular modeling studies of derivatives of a highly potent peptidomimetic vinyl ester as falcipain-2 inhibitors. |
| Q35020369 | Synthesis and pharmacological characterization of a new series of 5,7-disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazine derivatives as adenosine receptor antagonists: A preliminary inspection of ligand-receptor recognition process |
| Q38716039 | Synthesis, Anti-Breast Cancer Activity, and Molecular Docking Study of a New Group of Acetylenic Quinolinesulfonamide Derivatives. |
| Q56979465 | Synthesis, biological evaluation and molecular modeling studies of phthalazin-1(2H)-one derivatives as novel cholinesterase inhibitors |
| Q64935785 | Synthesis, comparative docking, and pharmacological activity of naproxen amino acid derivatives as possible anti-inflammatory and analgesic agents. |
| Q38668663 | Synthesis, evaluation and modeling of some triazolothienopyrimidinones as anti-inflammatory and antimicrobial agents |
| Q46789498 | Synthesis, modeling and biological evaluation of hybrids from pyrazolo[1,5c]pyrimidine as antileishmanial agents. |
| Q60919744 | Targeting Loxosceles spider Sphingomyelinase D with small-molecule inhibitors as a potential therapeutic approach for loxoscelism |
| Q26315519 | The Cytochrome P450 gene CYP6P12 confers pyrethroid resistance in kdr-free Malaysian populations of the dengue vector Aedes albopictus |
| Q36141471 | The Effectiveness of Natural Diarylheptanoids against Trypanosoma cruzi: Cytotoxicity, Ultrastructural Alterations and Molecular Modeling Studies |
| Q40558328 | The Rational Design, Synthesis, and Antimicrobial Properties of Thiophene Derivatives That Inhibit Bacterial Histidine Kinases |
| Q52857114 | The SQM/COSMO filter: reliable native pose identification based on the quantum-mechanical description of protein-ligand interactions and implicit COSMO solvation. |
| Q36474711 | The cytochrome P450 CYP6P4 is responsible for the high pyrethroid resistance in knockdown resistance-free Anopheles arabiensis. |
| Q99579575 | The cytotoxic potential of cationic triangulenes against tumour cells |
| Q38237899 | The receptor concept in 3D: from hypothesis and metaphor to GPCR-ligand structures |
| Q89575135 | Theoretical Model of EphA2-Ephrin A1 Inhibition |
| Q45760136 | Theoretical insight into the mechanism for the inhibition of the cysteine protease cathepsin B by 1,2,4-thiadiazole derivatives |
| Q92215786 | Towards accurate high-throughput ligand affinity prediction by exploiting structural ensembles, docking metrics and ligand similarity |
| Q92335348 | Tuning PFKFB3 Bisphosphatase Activity Through Allosteric Interference |
| Q40608421 | Using docking and alchemical free energy approach to determine the binding mechanism of eEF2K inhibitors and prioritizing the compound synthesis |
| Q36015308 | Vinardo: A Scoring Function Based on Autodock Vina Improves Scoring, Docking, and Virtual Screening |
| Q28068082 | Virtual Screening Approaches towards the Discovery of Toll-Like Receptor Modulators |
| Q41835114 | Virtual screening and in vitro assay of potential drug like inhibitors from spices against Glutathione-S-Transferase of Meloidogyne incognita |
| Q39756809 | Virtual screening and in vitro assay of potential drug like inhibitors from spices against glutathione-S-transferase of filarial nematodes |
| Q41014450 | Virtual screening for high affinity guests for synthetic supramolecular receptors |
| Q58176736 | Virtual screening for novel Atg5–Atg16 complex inhibitors for autophagy modulation |
| Q35556534 | Virtual screening of 2,3-disubstituted-4(3H)-quinazolinones possessing benzenesulfonamide moiety for COX-2 inhibitor. |
| Q34502788 | Virtual screening of CB(2) receptor agonists from bayesian network and high-throughput docking: structural insights into agonist-modulated GPCR features. |
| Q36591830 | Virtual screening of the inhibitors targeting at the viral protein 40 of Ebola virus |
| Q30393255 | VoteDock: consensus docking method for prediction of protein-ligand interactions |
| Q30421824 | When the lowest energy does not induce native structures: parallel minimization of multi-energy values by hybridizing searching intelligences |
| Q54355379 | Zinc ions modulate protein tyrosine phosphatase 1B activity. |
| Q33957660 | e-LEA3D: a computational-aided drug design web server |
| Q47166149 | eTOX ALLIES: an automated pipeLine for linear interaction energy-based simulations. |
| Q47287940 | iSMART: an integrated cloud computing web server for traditional Chinese medicine for online virtual screening, de novo evolution and drug design |
| Q47291934 | iScreen: world's first cloud-computing web server for virtual screening and de novo drug design based on TCM database@Taiwan |
| Q28306830 | istar: a web platform for large-scale protein-ligand docking |
| Q85113134 | pK(a) based protonation states and microspecies for protein-ligand docking |
| Q27902311 | vSDC: a method to improve early recognition in virtual screening when limited experimental resources are available |
Search more.